Scientists studying the effect of Copaxone on axonal health recently released
the results
of a four-year study. This study used magnetic resonance spectroscopy (MRS), an
imaging technique that can detect the presence of different molecules, to
analyze a particular region of the brain in MS subjects on Copaxone. Comparison
of the images taken at baseline to those taken four years later revealed an
increase in the levels of Naa, a component of axons. This increase was also seen
in some subjects who went on Copaxone midway through the study. These results
indicate that even over a period of several years, Copaxone is capable of
enhancing neuronal health and survival in MS.
